Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06564415

European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract Symptoms

European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Obstruction (BPO)

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,500 (estimated)
Sponsor
University of Florence · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to assess mid- and long-term effectiveness of Transperineal Laser Ablation of Prostate (TPLA) for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic obstruction measured by need and/or time until surgical retreatment. Data regarding patient-reported outcomes measures (PROMs), flowmetry parameters and safety about consecutive patients undergoing TPLA will be collected in a dedicated platform. Secondary objectives of the study are: * To assess functional and safety outcomes in patients treated with transperineal laser ablation for LUTS due to benign prostatic obstruction; * To identify possible differences in characteristics of patients treated with transperineal laser ablation among the centers and possible relations between treatment application and outcomes, in order to explore the optimal indications and possible limitations of TPLA for LUTS.

Conditions

Interventions

TypeNameDescription
PROCEDURETransperineal Laser Ablation of ProstateTransperineal Laser Ablation of the Prostate is an ultra minimally-invasive procedure that consists in the insertion trough the perineum skin of laser fibers into the prostatic adenoma, under US guidance. Laser energy generates an area of coagulative necrosis that will bring to a reduction of the prostatic volume.

Timeline

Start date
2024-01-11
Primary completion
2034-01-01
Completion
2034-01-01
First posted
2024-08-21
Last updated
2024-08-21

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06564415. Inclusion in this directory is not an endorsement.